Posted On: 01/08/2015 10:58:51 AM
Post# of 89360
$NRX Headlines
U.S. stocks soar; Dow stages 240-point rally 16 min ago - Anora Mahmudova
Biogen, Constellation gain; Family Dollar, Alexion drop 9:28 a.m. Today - MarketWatch
Strongest contrarian trade in years as bulls draw up another V-shape 9:07 a.m. Today - Shawn Langlois
WD-40 shares slip as results fall below Street view 6:49 p.m. Jan. 7, 2015 - Wallace Witkowski
Stocks finish solid year on down note; Dow drops 160 points 4:43 p.m. Dec. 31, 2014 - Victor Reklaitis
Denbury, Nabors slide; NephroGenex soars 9:56 a.m. Dec. 31, 2014 - Wallace Witkowski
Oil bottoms, stocks bubble, gold beckons 8:12 a.m. Dec. 31, 2014 - Shawn Langlois
Almost half of venture-backed IPOs this year are losers 5:00 a.m. Oct. 3, 2014 - Philip van Doorn
InsiderInsights.com Daily Round Up 1/6/15: XOMA, CODI, MNST, BBY 21 min ago - Seeking Alpha
NephroGenex up on positive feedback from EMA on Pyridorin trial 8:02 a.m. Today - Seeking Alpha
NephroGenex Hits 52-Week High on Pyridorin Safety Data - Analyst Blog 8:40 a.m. Jan. 2, 2015 - Zacks.com
Dow Logs Sixth Year of Gains 4:55 p.m. Dec. 31, 2014 - The Wall Street Journal Interactive Edition
NephroGenex (NRX) Stock Skyrockets to One-Year High Today After Lead Drug Safety Announcement 11:27 a.m. Dec. 31, 2014 - TheStreet.com
NephroGenex up big on Pyridorin safety study 8:52 a.m. Dec. 31, 2014 - Seeking Alpha
NephroGenex (NRX) CEO Pierre Legault on Q3 2014 Results - Earnings Call Transcript 11:07 a.m. Nov. 13, 2014 - Seeking Alpha
10-Q: NEPHROGENEX, INC. 4:17 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: NEPHROGENEX, INC. 3:14 p.m. Aug. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
NephroGenex's (NRX) CEO Pierre Legault on Q2 2014 Results - Earnings Call Transcript 8:41 a.m. Aug. 12, 2014 - Seeking Alpha
10-Q: NEPHROGENEX, INC. 6:33 a.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: NEPHROGENEX, INC. 11:03 a.m. March 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
IPO Preview: NephroGenex 11:54 p.m. Feb. 6, 2014 - Seeking Alpha
NephroGenex Announces that the European Medicines Agency Supports the Company’s Study Design for Ongoing Trial in Diabetic Nephropathy 5:00 p.m. Jan. 7, 2015 - BusinessWire - BZX
Daily Pharma Dose: New Research on Hospira, Aquinox, Sucampo, NephroGenex and OncoGenex 9:10 a.m. Dec. 31, 2014 - PR Newswire - PRF
NephroGenex Announces Positive Results for QT Study of Pyridorin 4:05 p.m. Dec. 30, 2014 - BusinessWire - BZX
NephroGenex Announces Closing of $12 Million Term Loan Facility 4:06 p.m. Nov. 20, 2014 - BusinessWire - BZX
NephroGenex, Inc. Announces Presentation at the American Society of Nephrology’s Kidney Week 2014 7:00 a.m. Nov. 13, 2014 - BusinessWire - BZX
NephroGenex Reports Third Quarter 2014 Financial Results 4:12 p.m. Nov. 12, 2014 - BusinessWire - BZX
NPS Pharma Appoints Pierre Legault to Board of Directors 4:31 p.m. Nov. 4, 2014 - BusinessWire - BZX
NephroGenex Announces Date of Conference Call to Discuss Third Quarter 2014 Financial Results 8:01 a.m. Nov. 3, 2014 - BusinessWire - BZX
NephroGenex to Participate in Two Healthcare Conferences in November 7:00 a.m. Oct. 31, 2014 - BusinessWire - BZX
NephroGenex Appoints Marco Taglietti, M.D. to Board of Directors 5:37 a.m. Oct. 1, 2014 - BusinessWire - BZX
NephroGenex to Present at the 13th Annual Bio Investor Forum 7:01 a.m. Sept. 30, 2014 - BusinessWire - BZX
NephroGenex To Participate in Four Healthcare Conferences in September 7:01 a.m. Sept. 2, 2014 - BusinessWire - BZX
NephroGenex Reports Second Quarter 2014 Financial Results 3:30 p.m. Aug. 11, 2014 - BusinessWire - BZX
NephroGenex Announces Date of Conference Call to Discuss Second Quarter 2014 Financial Results 7:00 a.m. July 31, 2014 - BusinessWire - BZX
NephroGenex, Inc. Initiates Pivotal Phase 3 Study With Novel Treatment to Slow Progression of Diabetic Kidney Disease 3:30 p.m. June 18, 2014 - BusinessWire - BZX
NephroGenex to Present at Jefferies 2014 Global Healthcare Conference In New York City 7:02 a.m. May 29, 2014 - BusinessWire - BZX
NephroGenex to Present at BioEquity Europe 2014 Conference 7:03 a.m. May 20, 2014 - BusinessWire - BZX
NephroGenex, Inc. Reports Year-End 2013 Financial Results 7:16 a.m. March 31, 2014 - GlobeNewswire
NephroGenex Announces Research Collaborations for Pivotal Studies of Pyridorin(TM) in Diabetic Nephropathy 7:14 a.m. March 27, 2014 - GlobeNewswire
NephroGenex Announces Closing of Initial Public Offering 11:30 a.m. Feb. 14, 2014 - GlobeNewswire
U.S. stocks soar; Dow stages 240-point rally 16 min ago - Anora Mahmudova
Biogen, Constellation gain; Family Dollar, Alexion drop 9:28 a.m. Today - MarketWatch
Strongest contrarian trade in years as bulls draw up another V-shape 9:07 a.m. Today - Shawn Langlois
WD-40 shares slip as results fall below Street view 6:49 p.m. Jan. 7, 2015 - Wallace Witkowski
Stocks finish solid year on down note; Dow drops 160 points 4:43 p.m. Dec. 31, 2014 - Victor Reklaitis
Denbury, Nabors slide; NephroGenex soars 9:56 a.m. Dec. 31, 2014 - Wallace Witkowski
Oil bottoms, stocks bubble, gold beckons 8:12 a.m. Dec. 31, 2014 - Shawn Langlois
Almost half of venture-backed IPOs this year are losers 5:00 a.m. Oct. 3, 2014 - Philip van Doorn
InsiderInsights.com Daily Round Up 1/6/15: XOMA, CODI, MNST, BBY 21 min ago - Seeking Alpha
NephroGenex up on positive feedback from EMA on Pyridorin trial 8:02 a.m. Today - Seeking Alpha
NephroGenex Hits 52-Week High on Pyridorin Safety Data - Analyst Blog 8:40 a.m. Jan. 2, 2015 - Zacks.com
Dow Logs Sixth Year of Gains 4:55 p.m. Dec. 31, 2014 - The Wall Street Journal Interactive Edition
NephroGenex (NRX) Stock Skyrockets to One-Year High Today After Lead Drug Safety Announcement 11:27 a.m. Dec. 31, 2014 - TheStreet.com
NephroGenex up big on Pyridorin safety study 8:52 a.m. Dec. 31, 2014 - Seeking Alpha
NephroGenex (NRX) CEO Pierre Legault on Q3 2014 Results - Earnings Call Transcript 11:07 a.m. Nov. 13, 2014 - Seeking Alpha
10-Q: NEPHROGENEX, INC. 4:17 p.m. Nov. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-Q: NEPHROGENEX, INC. 3:14 p.m. Aug. 12, 2014 - Edgar Online - (EDG = 10Q, 10K)
NephroGenex's (NRX) CEO Pierre Legault on Q2 2014 Results - Earnings Call Transcript 8:41 a.m. Aug. 12, 2014 - Seeking Alpha
10-Q: NEPHROGENEX, INC. 6:33 a.m. May 14, 2014 - Edgar Online - (EDG = 10Q, 10K)
10-K: NEPHROGENEX, INC. 11:03 a.m. March 31, 2014 - Edgar Online - (EDG = 10Q, 10K)
IPO Preview: NephroGenex 11:54 p.m. Feb. 6, 2014 - Seeking Alpha
NephroGenex Announces that the European Medicines Agency Supports the Company’s Study Design for Ongoing Trial in Diabetic Nephropathy 5:00 p.m. Jan. 7, 2015 - BusinessWire - BZX
Daily Pharma Dose: New Research on Hospira, Aquinox, Sucampo, NephroGenex and OncoGenex 9:10 a.m. Dec. 31, 2014 - PR Newswire - PRF
NephroGenex Announces Positive Results for QT Study of Pyridorin 4:05 p.m. Dec. 30, 2014 - BusinessWire - BZX
NephroGenex Announces Closing of $12 Million Term Loan Facility 4:06 p.m. Nov. 20, 2014 - BusinessWire - BZX
NephroGenex, Inc. Announces Presentation at the American Society of Nephrology’s Kidney Week 2014 7:00 a.m. Nov. 13, 2014 - BusinessWire - BZX
NephroGenex Reports Third Quarter 2014 Financial Results 4:12 p.m. Nov. 12, 2014 - BusinessWire - BZX
NPS Pharma Appoints Pierre Legault to Board of Directors 4:31 p.m. Nov. 4, 2014 - BusinessWire - BZX
NephroGenex Announces Date of Conference Call to Discuss Third Quarter 2014 Financial Results 8:01 a.m. Nov. 3, 2014 - BusinessWire - BZX
NephroGenex to Participate in Two Healthcare Conferences in November 7:00 a.m. Oct. 31, 2014 - BusinessWire - BZX
NephroGenex Appoints Marco Taglietti, M.D. to Board of Directors 5:37 a.m. Oct. 1, 2014 - BusinessWire - BZX
NephroGenex to Present at the 13th Annual Bio Investor Forum 7:01 a.m. Sept. 30, 2014 - BusinessWire - BZX
NephroGenex To Participate in Four Healthcare Conferences in September 7:01 a.m. Sept. 2, 2014 - BusinessWire - BZX
NephroGenex Reports Second Quarter 2014 Financial Results 3:30 p.m. Aug. 11, 2014 - BusinessWire - BZX
NephroGenex Announces Date of Conference Call to Discuss Second Quarter 2014 Financial Results 7:00 a.m. July 31, 2014 - BusinessWire - BZX
NephroGenex, Inc. Initiates Pivotal Phase 3 Study With Novel Treatment to Slow Progression of Diabetic Kidney Disease 3:30 p.m. June 18, 2014 - BusinessWire - BZX
NephroGenex to Present at Jefferies 2014 Global Healthcare Conference In New York City 7:02 a.m. May 29, 2014 - BusinessWire - BZX
NephroGenex to Present at BioEquity Europe 2014 Conference 7:03 a.m. May 20, 2014 - BusinessWire - BZX
NephroGenex, Inc. Reports Year-End 2013 Financial Results 7:16 a.m. March 31, 2014 - GlobeNewswire
NephroGenex Announces Research Collaborations for Pivotal Studies of Pyridorin(TM) in Diabetic Nephropathy 7:14 a.m. March 27, 2014 - GlobeNewswire
NephroGenex Announces Closing of Initial Public Offering 11:30 a.m. Feb. 14, 2014 - GlobeNewswire
(0)
(0)
